drugset / Trial / NCT00679666
Corneal Crosslinking in Keratoconus and Corneal Ectasia
RandomizedCrossoverOpen-labelTreatment
Summary
Prospective, randomized, single site to determine the safety and effectiveness of performing corneal collagen cross-linking (CXL) using riboflavin and UVA light in eyes progressive keratoconus or corneal ectasia.
Timeline
- Start
- 2008-04
- Primary completion
- 2010-04
- Completion
- 2010-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Riboflavin | Other / unclassified | 1 % | Topical |